Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing therapies using a precision approach to optimize clinical outcomes and significantly improve the lives of patients ...

The Switzerland-based firm's MosaiQ AiPlex Connective Tissue Diseases (CTDplus) assay is used to aid the diagnosis of autoimmune diseases.

Anifrolumab can substantially lower the risk for long-term organ damage progression in patients with moderate to severe ...

A risk prediction score that uses machine learning and a patient’s genetic information may identify autoimmune conditions up ...

The Lupus Foundation of America describes lupus as a chronic disease that attacks the immune system, the part of the body ...

Pericarditis recurrence in lupus is more likely — and has a dose-dependent relationship — with oral prednisone treatment, ...

Patients with cutaneous lupus erythematosus who used hydroxychloroquine had a significantly reduced risk of developing systemic lupus erythematosus.

After a previously reported positive phase 2 trial in systemic lupus erythematosus (SLE), the TYK2 inhibitor deucravacitinib ...

Charles River Laboratories International, Inc. CRL and Valo Health, Inc. recently announced an advanced product candidate for the treatment of different forms of lupus and other autoimmune indications ...

GRI Bio (GRI) announced the granting of two global patents. The granted patents include: Europe patent application No. 19,166,502 titled, ...

African Americans, particularly women, and residents of Southern states face disproportionately high rates of SLE-related mortality.